Active Conferences
P23002-15
Dallas 11/16/2023 Community Collective: Harnessing the Power of the Community to Battle Obesity
Release at:
16 November 2023
P22064-19 (Monongahela)
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Treating Acquired Resistance and Evaluating Next-generation Therapies
Release at:
13 November 2023
P22064-17 (Nashville)
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Treating Acquired Resistance and Evaluating Next-generation Therapies
Release at:
08 November 2023
P23002-14
Dallas 11/8/2023 - Community Collective: Harnessing the Power of the Community to Battle Obesity
Release at:
08 November 2023
P22106-08 (Coral Gables)
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Exploring Recent Data and Treatment Strategies
Release at:
03 November 2023
P22064-21 (Canton)
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Treating Acquired Resistance and Evaluating Next-generation Therapies
Release at:
03 November 2023
P23002-13
Dallas 11/01/2023 - Community Collective: Harnessing the Power of the Community to Battle Obesity
Release at:
01 November 2023
P22106-19 (New Orleans)
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Exploring Recent Data and Treatment Strategies
Release at:
27 October 2023
P23002-06
Boston 10/26/2023 - Community Collective: Harnessing the Power of the Community to Battle Obesity
Release at:
26 October 2023
P22082- 09 (Portland)
First-Line Treatment of CLL and SLL: Practical Strategies for Oncology Nurses for ONS Chapters
Release at:
21 October 2023
P22066-12 (Portland)
Biomarker-based Therapy for NSCLC: Improving Collaboration, Communication, and Care
Release at:
21 October 2023
P22066-11 (Phoenix)
Biomarker-based Therapy for NSCLC: Improving Collaboration, Communication, and Care
Release at:
19 October 2023
P22064-07 (Nashville)
Making the Right Call: Biomarker Testing and Targeting in NSCLC Equitable, Guideline-based Testing for Prognosis and Treatment
Release at:
18 October 2023
P22064-18 (Evansville)
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Treating Acquired Resistance and Evaluating Next-generation Therapies
Release at:
17 October 2023
P22064-11-Canton, OH
Biomarker Testing and Targeting in NSCLC: Equitable, Guideline-based Testing for Prognosis and Treatment
Release at:
06 October 2023
P22064-08 -Evansville, IN
Making the Right Call: Biomarker Testing and Targeting in NSCLC Equitable, Guideline-based Testing for Prognosis and Treatment
Release at:
03 October 2023
P22106-14- Hopkins
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Real-world Applications in Clinical Practice
Release at:
29 September 2023
P22106- 09 (New Orleans, LA)
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Exploring Recent Data and Treatment Strategies
Release at:
22 September 2023
P23018-05 - IASP 2023
A Practical Approach to Skin Biopsy - From Acquisition to Analysis
Release at:
08 September 2023
P23018-04 - IASP 2023
Comprehensive Assessment of Neuropathic Pain: Neurological Exam and Quantitative Sensory Testing Hands-on Workshop
Release at:
07 September 2023
P23018-01 - IASP 2023
NeuPSIG 2023 International Congress on Neuropathic Pain
Release at:
07 September 2023
P23003-01 (SOHO)
The Society of Hematologic Oncology 2023 Eleventh Annual Meeting
Release at:
06 September 2023
P22064-09 Monongahela
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Part I: Equitable, Guideline-based Testing for Prognosis and Treatment
Release at:
28 August 2023
P2064-16- Staten Island- Part 2
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Treating Acquired Resistance and Evaluating Next-generation Therapies
Release at:
10 August 2023
P22064-06 Staten Island
Making the Right Call: Biomarker Testing and Targeting in NSCLC Equitable, Guideline-based Testing for Prognosis and Treatment
Release at:
27 July 2023
P22066-10 (Wauwatosa)
Biomarker-based Therapy for NSCLC: Improving Collaboration, Communication, and Care
Release at:
19 July 2023
P22064-15-Miami
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Treating Acquired Resistance and Evaluating Next-generation Therapies (Part 2)
Release at:
10 July 2023
P22064-05-Miami
Making the Right Call: Biomarker Testing and Targeting in NSCLC Equitable, Guideline-based Testing for Prognosis and Treatment
Release at:
23 June 2023
Medical Learning Institute, Inc.
40946 US Highway 19N, #602
Tarpon Springs, FL, 34689
888.654.2631 (toll-free)
609.333.1693 (direct)
Copyright © 2023 Medical Learning Institute, Inc. All Rights Reserved.